MANSFIELD, MASSACHUSETTS, May 18, 2020- Mansfield Bio-Incubator is pleased to announce our new member company, Geistek Pharma. Geistek is an innovative Pharmaceutical Company that classifies as a Contract Research Organization focused on pre-clinical and clinical research projects. Our work consists of giving administrative and technical support to Clinical and pre-clinical Trials in the field of Advanced Therapies. Something that makes us different is that we use the Artificial Intelligence technology and Machine Learning for processing data and giving an appropriate forecast to the future results of the experiments the research groups will perform.
“We aspire to be the first full service CRO in the world specialized in Advanced Therapies such as genetic, cellular and protein therapies. These therapies are one of the fields of medicine with the greatest prospects for future development, due to its potential ability to cure diseases that do not find effective treatments in conventional therapies and its ability to focus on patients' characteristics with personalized medicine.” said Diego Fajardo Puig, the CEO. Geistek has been nominated to be one of the 20 Most Innovative Companies of 2020 by Business Worldwide magazine.
Geistek’s headquarters are located in Madrid, Spain. Geistek’s virtual membership at Mansfield Bio-Incubator enables the company to formulate the strategy to expand into the US market. For more information, please visit the website at https://geistek.com/.
Mansfield Bio-Incubator is a non-profit biotech, pharma, life science, and medical device business incubator facility. Our mission is to facilitate and assist the creation, growth, and success of the next generation of biotech, pharma, life science, and medical device companies. We were created to nurture entrepreneurial and economic development in the community. We aim to do this by maintaining affordable lab and office space and making cutting-edge technology, services, training, mentoring, and a network of professional advisors available to small biotechnology companies and healthcare-related start-ups.